{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Sarfo FS"],"funding":["National Heart, Lung, and Blood Institute","NHLBI NIH HHS","NINDS NIH HHS"],"pagination":["105401"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC8809888"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["29(12)"],"pubmed_abstract":["<h4>Background and purpose</h4>There are limited data evaluating the characteristics of apparent treatment-resistant hypertension (aTRH) among stroke survivors in sub-Saharan Africa. We aimed to conduct a comparative analysis of the frequency and factors associated with aTRH among stroke survivors and stroke-free individuals with hypertension in Ghana.<h4>Methods</h4>Cross-sectional multicenter study involving five hospitals in Ghana conducted between July 2015 and June 2018. Clinic-based blood pressure was measured using a standardized protocol and antihypertensive medications assessed via review of medical records and inspection of pills. aTRH was defined as either office BP ≥140/90mmHg on ≥3 classes of antihypertensive medications or on ≥4 antihypertensive medications regardless of BP. "],"journal":["Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association"],"pubmed_title":["Apparent Treatment Resistant Hypertension Among Stroke Survivors in Ghana."],"pmcid":["PMC8809888"],"funding_grant_id":["R01 HL152188","R21 NS103752"],"pubmed_authors":["Ovbiagele B","Sarfo FS"],"additional_accession":[]},"is_claimable":false,"name":"Apparent Treatment Resistant Hypertension Among Stroke Survivors in Ghana.","description":"<h4>Background and purpose</h4>There are limited data evaluating the characteristics of apparent treatment-resistant hypertension (aTRH) among stroke survivors in sub-Saharan Africa. We aimed to conduct a comparative analysis of the frequency and factors associated with aTRH among stroke survivors and stroke-free individuals with hypertension in Ghana.<h4>Methods</h4>Cross-sectional multicenter study involving five hospitals in Ghana conducted between July 2015 and June 2018. Clinic-based blood pressure was measured using a standardized protocol and antihypertensive medications assessed via review of medical records and inspection of pills. aTRH was defined as either office BP ≥140/90mmHg on ≥3 classes of antihypertensive medications or on ≥4 antihypertensive medications regardless of BP. ","dates":{"release":"2020-01-01T00:00:00Z","publication":"2020 Dec","modification":"2025-04-19T13:19:37.046Z","creation":"2025-04-19T13:19:37.046Z"},"accession":"S-EPMC8809888","cross_references":{"pubmed":["33096498"],"doi":["10.1016/j.jstrokecerebrovasdis.2020.105401"]}}